Other OTC - Delayed Quote • USD
Provectus Biopharmaceuticals, Inc. (PVCT)
At close: April 26 at 3:50 PM EDT
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | PVCT | S&P 500 |
---|---|---|
YTD | +106.77% | +6.92% |
1-Year | +41.79% | +25.26% |
3-Year | +183.57% | +22.00% |